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Abstract
Beta-binomial/Poisson models have been used by many authors to model multivari-
ate count data. Lora and Singer (Statistics in Medicine, 2008) extended such models
to accommodate repeated multivariate count data with overdipersion in the binomial
component. To overcome some of the limitations of that model, we consider a beta-
binomial/gamma-Poisson alternative that also allows for both overdispersion and differ-
ent covariances between the Poisson counts. We obtain maximum likelihood estimates
for the parameters using a Newton-Raphson algorithm and compare both models in a
practical example.
Key words: bivariate counts, longitudinal data, overdispersion, random effects, regres-
sion models
1 Introduction
Beta-binomial models have been used by many authors to model binomial count data with
different probabilities of success among units from the same group of study. Williams
(1975) used such distributions to compare the number of fetal abnormalities of pregnant
rat females on a chemical diet during pregnancy to a control group, both with fixed litter
size. Gange et al. (1996) analyzed the quality of health services (classified as appropriate
or not) during patient stay in a hospital using a similar approach. To analyze mortality
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data in mouse litters with a fixed number of implanted fetuses, Brooks et al. (1997) used
such models not only to allow for different probabilities of success among units from the
same group of study, but also to consider overdispersion among them. Given that in many
studies, the number of trials may not be fixed, Comulada and Weiss (2007) considered a
multivariate Poisson distribution to model the number of successes and failures in a random
number of attempts, illustrating their proposal with data from a HIV transmission study.
Multivariate Poisson distribution have also been used to model correlated count data, as
in Karlis and Ntzoufras (2003) who used such distribution to model the number of goals of
two competing teams.
In a study where the number of successes in a random number of trials was observed
repeatedly, and therefore are possibly correlated, Lora and Singer (2008) consider multi-
variate beta-binomial/Poisson models. In their proposal, the beta-binomial component also
accounts for overdispersion across units with the same levels of covariates. The multivari-
ate Poisson component accommodates both the random number of trials and the repeated
measures nature of the data. The effect of possible covariates is taken into account via
the regression approach suggested by Ho and Singer (1997, 2001). Their model, however,
requires a constant covariance term between the repeated number of trials and does not
allow for overdispersion in these counts. Since, as suggested by Cox (1983), the precision
of parameter estimates may be seriously affected when overdispersion is not accounted for
in the models considered for analysis, we propose a beta-binomial/gamma-Poisson model
that not only incorporates such characteristics but is also easier to implement computa-
tionally. The model, along with maximum likelihood methods for estimation and testing
purposes are presented in Section 2. An illustration using data previously analyzed by Lora
and Singer (2008) is presented in Section 3. A brief discussion and suggestions for future
research are outlined in Section 4.
2 The beta-binomial/gamma-Poisson model for repeated mea-
surements
We denote the vector of responses for the g-th sample unit (g = 1, . . . ,M) by
Yg = (Xg1, Ng1, ...,Xgp, Ngp)
′
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with Xgh corresponding to the number of successes in Ngh trials performed under the h-th
(h = 1, . . . , p) observation condition. We assume that for all g and h,
Xgh | Ngh, pigh follow independent binomial(Ngh, pigh) distributions (1)
pigh follow independent Beta(µ(zµgh)/θ(zθgh), [1 − µ(zµgh)]/θ(zθgh)) distributions(2)
Ngh | τg follow independent Poisson(λ(zλgh)τg) distributions (3)
τg follow independent gamma(α(zαg)/δ(zδg), 1/δ(zδg)) distributions (4)
where zµgh, zθgh, zλgh, zαg and zδg are vectors of fixed covariates.
According to (1) and (2), the success probabilities may be different across units, but
they are generated by beta distributions that may depend on covariates. In (3) and (4),
we follow Nelson (1985) to specify that the numbers of trials may also be different across
units, but are generated by gamma distributions that may also depend on covariates.
The parametrizations (0 < µ < 1, θ > 0) adopted in (2) and (α > 0, δ > 0) adopted
in (4) are used to facilitate maximum likelihood estimation, as suggested by Gange et
al. (1996); their relation to the usual beta(a, b) parametrization, as in Johnson and Kotz
(1970), and the usual gamma(c, d) parametrization, as in Mood et al. (1974), is given by
µ =
a
a+ b
, θ =
1
a+ b
, α =
c
d
and δ =
1
d
.
The first and second order central moments of τg in (4) are
E(τg) = α(zαg) (5)
V ar(τg) = α(zαg)δ(zδg) (6)
From (3) and (4), the first and second order central moments of the number of trials are
E(Ngh) = λ(zλgh)α(zαg) (7)
V ar(Ngh) = λ(zλgh)α(zαg){1 + λ(zλgh)δ(zδg)} (8)
Cov(Ngh, Ngh′) = λ(zλgh)λ(zλgh′)α(zαg)δ(zδg) (9)
for all g, h, h′, h 6= h′. Similarly, the first and second order central moments of pigh in (2)
are
E(pigh) = µ(zµgh) (10)
V ar(pigh) = µ(zµgh)[1 − µ(zµgh)]θ(zθgh)[1 + θ(zθgh)]
−1 (11)
Also, from (1) and (2), we may conclude that, for all g and h,
Xgh | Ngh ∼ beta− binomial[Ngh, µ(zµgh), θ(zθgh)]
with
E(Xgh) = µ(zµgh)λ(zλgh)α(zαg) (12)
V ar(Xgh) = µ(zµgh)[1− µ(zµgh)]
θ(zθgh)
1 + θ(zθgh)
λ2(zλgh)α(zαg)[α(zαg) + δ(zδg)]
+µ(zµgh)λ(zλgh)α(zαg)[1 + µ(zµgh)λ(zλgh)δ(zδg)] (13)
Cov(Xgh,Xgh′) = µ(zµgh)µ(zµgh′)λ(zλgh)λ(zλgh′)α(zαg)δ(zδg) (14)
for all g, h, h′, h 6= h′. The covariance between the numbers of successes and trials is
Cov(Xgh, Ngh) = µ(zµgh)λ(zλgh)α(zαg){1 + λ(zλgh)δ(zδg)}. (15)
The parameters θ(zθgh) govern both the variability of the success probabilities and the
overdispersion of the number of successes, that may also depend on the parameter δ(zδg).
When θ(zθgh) and δ(zδg) are equal to zero, there is no overdispersion for the number of
successes. The parameters δ(zδg) are also related to the variability and overdispersion of
the number of trials and to the covariance between the numbers of trials and numbers of
successes. When δ(zδg) = 0, the repeated counts are independent.
To investigate the effects of covariates, we adopt log-linear models of the form
µ(zµgh) =
exp(z′µghβµ)
1 + exp(z′µghβµ)
(16)
θ(zθgh) = exp(z
′
θghβθ) (17)
λ(zλgh) = exp(z
′
λghβλ) (18)
α(zαg) = exp(z
′
αgβα) (19)
δ(zδg) = exp(z
′
δgβδ) (20)
where βµ, βθ, βλ, βα and βδ are vectors of parameters to be estimated.
From (1), (2), (3) and (4) it follows that the joint probability mass function for the
number of trials and successes for the g-th unit is
P (Xg1, Ng1, ...,Xgp, Ngp) =
p∏
h=1
P (Xgh | Ngh)P (Ng1, ..., Ngp)
=
p∏
h=1
P (Xgh | Ngh)
(∫
∞
0
p∏
h=1
P (Ngh | τg)f(τg)dτg
)
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with f denoting the density of (4). Since the logarithm of the likelihood is given by
logL(βµ,βθ,βλ,βα,βδ) =
=
M∑
g=1
p∑
h=1
logP (Xgh | Ngh,βµ,βθ) +
M∑
g=1
logP (Ng1, ..., Ngp | βλ,βα,βδ),
the parameters of the beta-binomial distribution (βµ,βθ) can be estimated separately from
those of the gamma-Poisson distribution (βλ,βα,βδ).
The beta-binomial probability mass function can be written as
P (Xgh = xgh | Ngh = ngh,βµ,βθ) =
(
ngh
xgh
){
Γ
(
1
θ(zθgh)
)[
Γ
(
1
θ(zθgh)
+ ngh
)]
−1
}
×
{
Γ
(
µ(zµgh)
θ(zθgh)
+ xgh
)[
Γ
(
µ(zµgh)
θ(zθgh)
)]
−1
}
×
{
Γ
(
1− µ(zµgh)
θ(zθgh)
+ ngh − xgh
)[
Γ
(
1− µ(zµgh)
θ(zθgh)
)]
−1
}
=
(
ngh
xgh
) ngh−1∏
u=0
[1 + uθ(zθgh)]
−1
xgh−1∏
v=0
[µ(zµgh) + vθ(zθgh)]
×
ngh−xgh−1∏
w=0
[1− µ(zµgh) + wθ(zθgh)] (21)
where Γ(r) =
∫
∞
0 t
r−1e−tdt. The expressions involving ratios between two gamma functions
(presented within brackets) make sense when ngh 6= 0 (in the first ratio), xgh 6= 0 (in the
second ratio) and xgh 6= ngh (in the third ratio). When these conditions are not satisfied,
the ratios between the gamma functions may be set equal to one, and do not affect the
conditional probability of Xgh given Ngh,βµ,βθ.
The kernel of the beta-binomial log-likelihood function is
L(βµ,βθ) =
M∑
g=1
p∑
h=1

xgh−1∑
v=0
log[µ(zµgh) + vθ(zθgh)]+
ngh−xgh−1∑
w=0
log[1− µ(zµgh) +wθ(zθgh)]−
ngh−1∑
u=0
log[1 + uθ(zθgh)]

 (22)
and we may use maximum likelihood methods adopting a Newton-Raphson iterative process
to estimate βµ and βθ. The first and second derivatives of (22) are shown in Lora and Singer
(2008). Method of moments estimates based on the beta-binomial distribution may be used
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as initial values for µ(zµgh) and θ(zθgh), as suggested by Griffiths (1973). Likelihood ratio
tests may be employed for model reduction purposes, i.e., for constructing a parsimonious
model that captures the explainable variability in the data. For example, to verify if the
q-parameter vector β∗ is null, the test statistics LR = 2(L − L∗), with L∗ indicating the
log-likelihood under H0 and L, this logarithm under the alternative hypothesis may be
employed. Asymptotically, LR follows a chi-squared distribution with q degrees of freedom
under the null hypothesis.
The probability function for the repeated number of trials based in (3) and (4) is
P (Ng1 = ng1, ..., Ngp = ngp|βλ,βα,βδ) =
=
p∏
h=1
{
[λ(zλgh)]
ngh
ngh!
}[
1
δ(zδg)
]α(zαg)/δ(zδg)
Γ
(
p∑
h=1
ngh +
α(zαg)
δ(zδg)
){
Γ
(
α(zαg)
δ(zδg)
)}
−1
÷
[
p∑
h=1
λ(zλgh) +
1
δ(zδg)
]Σp
h=1
ngh+α(zαg)/δ(zδg)
=
p∏
h=1
{
[λ(zλgh)]
ngh
ngh!
} Σp
h=1
ngh−1∏
u=0
[α(zαg) + uδ(zδg)]
÷
{
δ(zδg)
[
p∑
h=1
λ(zλgh)
]
+ 1
}Σp
h=1
ngh+α(zαg)/δ(zδg)
(23)
In (23), the simplifications for the rations between two gamma functions make sense when∑p
h=1 ngh 6= 0. When this condition is not satisfied, the ratio is also set equal to one, and
it does not affect the probability value.
The kernel of the gamma-Poisson log-likelihood function is
L(βλ,βα,βδ) =
M∑
g=1


p∑
h=1
[nghlogλ(zλgh)] +
Σp
h=1
ngh−1∑
u=0
log[α(zαg) + uδ(zδg)]
−
[
p∑
h=1
ngh +
α(zαg)
δ(zδg)
]
log
[
δ(zδg)
(
p∑
h=1
λ(zλgh)
)
+ 1
]}
(24)
and we adopt the same methods used with the beta-binomial model to estimate βλ,βα and
βδ. The first and second derivatives of (24) are shown at the Appendix. Method of moments
estimates may be used used as the initial values for λgh(zλ), αg(zα) and δ(zδ) here, too.
Likelihood ratio tests may be employed for model reduction purpose, along similar lines as
those considered for the beta-binomial model.
Both iterative processes are implemented in the R software and the corresponding code
can be downloaded from http://www.ime.usp.br/∼jmsinger.
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3 Data analysis
To compare the beta-binomial/gamma-Poisson to the multivariate beta-binomial/Poisson
model, we consider the same data presented in Lora and Singer (2008) from a study con-
ducted at the Learning Laboratory of the Department of Physiotherapy, Phonotherapy and
Occupational Therapy of the University of Sa˜o Paulo, Brazil, to evaluate the performance
of some motor activities of Parkinson’s disease patients. For the sake of completeness, we
repeat the description of the study here. Twenty five patients with confirmed clinical di-
agnosis of Parkinson’s disease and twenty one normal (without any preceding neurologic
alterations) subjects repeated two sequences of specified opposed finger movements (touch-
ing one of the other four fingers with the thumb) during one minute periods, with both
hands. This was done both before and after a four-week experimental period in which
only one of the sequences was trained (active sequence) with one of the hands; the other
sequence was not trained (control sequence). Half of the subjects in each group trained the
preferred hand (right for the right-handed and left for the left-handed in the normal group
or the less affected by the disease in the experimental group) and the other half trained the
non-preferred hand. Information on the number of attempted and successful trials were
recorded with a special device attached to a computer.
Six subgroups may be characterized by the combination of disease stage (normal, ini-
tial or advanced) and use of the preferred hand (yes or no). The repeated measures are
characterized by the cross-classification of the levels of sequence (control or active) and
evaluation session (baseline or final). The specific objective of the study was to evaluate
whether training is associated with increases in the expected number of attempted trials
per minute (agility) and/or on the probability of successful trials (ability). Note that the
treatment could improve agility without improving ability, so an evaluation of its effect on
both characteristics is important.
The means and variances of the number of attempted and successful trials at the baseline
and final evaluations with the active and control sequences for patients at the different dis-
ease stages using the preferred or non-preferred hands are presented in Table 1. Variances,
instead of standard deviations, are displayed to facilitate identification of overdispersion in
the sense referred by Nelder and McCullagh (1989), i.e., cases where variances are greater
than expected under Poisson or binomial distributions. Overdispersion in the number of
attempts, under a Poisson distribution is clearly identified by comparing the observed mean
and variance; for the number of successes, on the other hand, it is necessary to compare the
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observed and expected variances under the binomial distribution (np(1− p)). For example,
considering normal subjects performing the active sequence at the baseline session using the
preferred hand, the expected variance under the binomial model is 1.4, while the observed
variance is 49.0, highlighting the overdispersion for these counts too.
Correlation coefficients for the within-subject responses for the normal patients using
the preferred hand are displayed in Table 2. For this subgroup, only 3 out of the 28 observed
correlations are smaller than 0.60; this suggests that the counts are probably related and it
is sensible to use a model that can accommodate this relationship. The correlation patterns
for the other subgroups are similar and are not presented.
The analysis strategy consisted in fitting initial models of the form (16)-(20) with all
main effects and first order interactions, and trying to reduce them by sequentially elimi-
nating the non-significant terms. The parameters are indexed by disease stage (0=normal,
1=initial, 2=advanced), intervention hand (P=preferred, N=non-preferred), evaluation ses-
sion (B=baseline, F=final) and sequence (C=control, A=active). We adopted a reference
cell parameterization with the reference cell corresponding to the normal group (0), per-
forming the active sequence (A) with the preferred hand (P) at the baseline evaluation
(B).
3.1 Modelling the expected probability and dispersion of successful at-
tempts
For both beta-binomial/gamma-Poisson and multivariate beta-binomial/Poisson models,
the parameters of the beta-binomial components can be estimated separately from those
of the gamma-Poisson or the multivariate Poisson distributions. Therefore, modelling the
expected probabilities and dispersion parameters of the successful attempts is exactly the
same as in Lora and Singer (2008) and it is not shown here; we present only the estimates
and standard errors computed under the final beta-binomial model (Table 3) for comparison
with the results obtained under the beta-binomial/gamma-Poisson model. Under this final
model, estimates of the expected probabilities of successful attempts [E(pigh) = µ(zµgh)] and
dispersion parameters θ(zθgh) (that govern the variability of the probabilities of successful
attempts), along with their standard errors, are presented in Table 4.
The results suggest no evidence of difference between the expected probabilities of
successful attempts for patients using preferred or non-preferred hand (βµN = 0), neither
for active nor for control sequences in the baseline session (βµC = 0). Patients in the normal
group or with the disease in initial stage have similar expected probabilities of successful
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Table 1: Mean and variance (within parentheses) of the number of attempted and successful
trials.
Disease Evaluation Intervention Sequence Successes Attempts
stage session hand
Normal Baseline Preferred Control 17.1 (49.0) 18.6 (46,2)
Normal Baseline Preferred Active 17.1 (72.3) 17.9 (79.2)
Normal Baseline Non-preferred Control 18.1 (27.0) 20.9 (47.6)
Normal Baseline Non-preferred Active 17.1 (37.2) 19.5 (53.3)
Normal Final Preferred Control 20.9 (90.3) 26.1 (44.9)
Normal Final Preferred Active 32.7 (139.2) 33.1 (132.3)
Normal Final Non-preferred Control 24.2 (25.0) 28.6 (38.4)
Normal Final Non-preferred Active 32.8 (74.0) 34.4 (72.3)
Initial Baseline Preferred Control 13.7 (24.0) 16.3 (44.9)
Initial Baseline Preferred Active 12.0 (23.0) 13.5 (23.0)
Initial Baseline Non-preferred Control 12.0 (17.6) 14.6 (9.0)
Initial Baseline Non-preferred Active 10.7 (20.3) 13.6 (10.9)
Initial Final Preferred Control 13.2 (30.3) 16.8 (43.6)
Initial Final Preferred Active 20.2 (9.6) 21.8 (2.9)
Initial Final Non-preferred Control 15.3 (112.4) 20.3 (116.6)
Initial Final Non-preferred Active 20.1 (33.6) 20.4 (39.7)
Advanced Baseline Preferred Control 4.8 (22.1) 7.1 (11.6)
Advanced Baseline Preferred Active 4.6 (11.6) 7.9 (14.4)
Advanced Baseline Non-preferred Control 8.3 (72.3) 12.5 (15.2)
Advanced Baseline Non-preferred Active 13.5 (92.2) 15.5 (57.8)
Advanced Final Preferred Control 7.4 (75.7) 11.9 (67.2)
Advanced Final Preferred Active 13.5 (90.3) 14.9 (77.4)
Advanced Final Non-preferred Control 5.8 (31.4) 12.8 (12.3)
Advanced Final Non-preferred Active 22.5 (75.7) 23.8 (75.7)
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Table 2: Correlation coefficients for the within-subject responses for the normal subjects
using the preferred hand
Baseline session Final session
Active seq. Control seq. Active seq. Control seq.
Suc. Att. Suc. Att. Suc. Att. Suc. Att.
Baseline Active Suc. 1
session seq. Att. 0.99 1
Control Suc. 0.85 0.84 1
seq. Att. 0.78 0.80 0.96 1
Final Active Suc. 0.76 0.76 0.61 0.61 1
session seq. Att. 0.74 0.74 0.61 0.63 0.99 1
Control Suc. 0.53 0.49 0.59 0.63 0.60 0.61 1
seq. Att. 0.81 0.82 0.70 0.69 0.93 0.92 0.50 1
Codes: Suc.=Successes, Att.=Attempts and seq.=sequence
attempts (βµ1 = 0), but those with the disease in an advanced stage have smaller expected
probabilities of successful attempts (βµ2 < 0). Moreover, an intervention effect is detected
since the expected probabilities of successful attempts in the final session are greater than
those for the baseline session (βµF > 0). These values are smaller for the control sequence
than for the active sequence (βµF + βµ(F∗C) < 0) suggesting that training is effective with
respect to ability.
We may also infer that there is no difference between the expected dispersion parameter
for subjects performing the active and control sequences (βθC = 0). For the normal subjects,
the expected dispersion parameters are the same (βθC , βθN , βθF=0), except in the final
evaluation using the non-preferred hand, for which the expected value is smaller than the
others (βθ(F∗N) < 0). For patients in initial stage of the disease, the expected dispersion
parameters are smaller than for those in the normal group (βθ1 < 0); however, they change
for each combination of session and intervention hand (βθ(1∗F ), βθ(1∗N), βθ(F∗N) 6= 0).
Finally, for patients in the advanced stage of the disease, the expected dispersion parameter
is larger than for those in the normal group (βθ2 > 0), but this changes for the final session
when the non-preferred hand is used (βθ(F∗N) 6= 0).
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Table 3: Parameter estimates and standard errors under the final beta-binomial model
Standard
Parameter Related to Estimate error
βµ0 Normal group, preferred hand, 1.86 0.15
baseline session and active sequence
βµ2 Effect of advanced stage -1.35 0.25
βµF Effect of final session 1.38 0.30
βµ(F∗C) Effect of final session and control sequence -1.79 0.30
βθ0 Normal group, preferred hand, -1.07 0.27
baseline session and active sequence
βθ1 Effect of initial stage -2.98 1.05
βθ2 Effect of advanced stage 1.31 0.37
βθ(1∗F ) Effect of disease in initial stage and final session 1.66 0.82
βθ(1∗N) Effect of initial stage and non-preferred hand 2.78 0.91
βθ(F∗N) Effect of final session and non-preferred hand -1.49 0.44
3.2 Modelling the expected number of attempts
The initial model parameter vector, with all main effects and first order interactions is
β = (βλ,βα,βδ) where
βλ = (βλ0, βλ1, βλ2, βλN , βλF , βλC ,
βλ(1∗F ), βλ(1∗N), βλ(1∗C), βλ(2∗F ), βλ(2∗N), βλ(2∗C), βλ(F∗N), βλ(F∗C), βλ(N∗C))
βm = (βm0, βm1, βm2, βmN , βm(1∗N), βm(2∗N))
with m = α, δ. We may interpret βλ0 as the logarithm of λ for normal individuals, using
the preferred hand, performing the active sequence at the final evaluation; βλN corresponds
to the variation in the logarithm of λ due to the effect of the non-preferred hand compared
to the preferred one; βλ(1∗N) corresponds to an additional variation in the logarithm of λ
due to the interaction between the initial stage of the disease (1) and the use of the non-
preferred hand (N). The elements of the vector βλ related to different evaluation sessions
(represented by F and C) allow for different number of attempts in these different evaluation
sessions. On the other hand, α(zαg) and δ(zδg) do not vary in different evaluation sessions;
therefore the vectors βα and βδ do not have elements to distinguish between sessions, but
have elements to compare subgroups.
As noticed in Lora and Singer (2008) for the beta-binomial model, the iterative process
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Table 4: Estimates of expected probabilities of successful attempts, dispersion parameters
and standard errors under the final beta-binomial model
Disease Evaluation Intervention Expected Standard
stage session hand Sequence value error
Expected probabilities of successful attempts
Normal or initial Baseline Either Either 0.87 0.02
Normal or initial Final Either Control 0.81 0.03
Normal or initial Final Either Active 0.96 0.01
Advanced Baseline Either Either 0.62 0.06
Advanced Final Either Control 0.52 0.06
Advanced Final Either Active 0.87 0.04
Dispersion parameters
Normal Baseline Either Either 0.34 0.09
Normal Final Preferred Either 0.34 0.09
Normal Final Non-preferred Either 0.08 0.03
Initial Baseline Preferred Either 0.02 0.02
Initial Baseline Non-preferred Either 0.28 0.14
Initial Final Preferred Either 0.09 0.06
Initial Final Non-preferred Either 0.33 0.19
Advanced Baseline Either Either 1.27 0.37
Advanced Final Preferred Either 1.27 0.37
Advanced Final Non-preferred Either 0.29 0.13
was very sensitive to initial values, specially for the interactions. To overcome this difficulty,
we started with a simpler model containing only the main effects and used the resulting
estimates as initial values for fitting other models, obtained by including the interactions one
by one. The estimates of the interaction parameters obtained in this preliminary process
were used as the initial values in our modelling strategy.
The non-significant interactions were identified and their simultaneous elimination from
the initial model was supported (p = 0.211) via a test of the hypothesis
H0 : βλ(1∗F ), βλ(1∗N), βλ(1∗C), βλ(2∗F ), βλ(2∗N), βλ(2∗C), βλ(F∗N), βλ(N∗C),
βα(1∗N), βα(2∗N), βδ(1∗N), βδ(2∗N) = 0
Under the resulting reduced model, the non-significant main effects were identified; their
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simultaneous elimination was corroborated (p = 0.493) via a test of the hypothesis
H0 : βλN , βλC , βα1, βα2, βαN , βδ1, βδ2, βδN = 0.
We considered other hypotheses where some of these parameters are equal to zero and they
were all rejected (p < 0.150). Goodness of fit of the resulting reduced model was confirmed
by a likelihood ratio test in which it was compared to the initial model (p = 0.289).
For this final model, the corresponding parameter estimates along with their standard
errors are presented in Table 5. Based on this, we estimated expected values for λ(zλgh);
the results are presented in Table 6. Additionally, since only the parameters βα0 and βδ0
were included at the final model, we have α(zαg) = 3.67, with standard error of 0.18, and
δ(zδg) = 0.27, with standard error of 0.07, for all disease stages and both hands. The
non-zero estimate of δ suggests that the total attempts are overdispersed and that the
correlations among the counts across the different instants of evaluation are non-null.
Table 5: Parameter estimates and standard errors for the final gamma-Poisson model
Parameter Related to Estimate Standard error
βλ0 Normal group, preferred hand, 1.68 0.03
initial evaluation and active sequence
βλ1 Effect of initial stage -0.38 0.05
βλ2 Effect of advanced stage -0.71 0.05
βλF Effect of final evaluation 0.52 0.04
βλ(F∗C) Effect of final evaluation and control sequence -0.22 0.05
βα0 Normal group, preferred hand 1.30 0.05
βδ0 Normal group, preferred hand -1.32 0.25
We may conclude that individuals in the initial stage of the disease have smaller expected
number of attempts than normal ones, and for individuals in the advanced stage this value
is even smaller (βλ2 < βλ1 < 0 and βα1 = βα2 = 0). There is no evidence of difference
between the expected number of attempts for participants using preferred or non-preferred
hands (βλN = 0 and βαN = 0), neither for active nor for control sequences in the baseline
session (βλC = 0). The results suggest that the training is also effective with respect to
agility, since the expected number of attempts under the final evaluation is bigger than
at the initial one (βλF > 0). Moreover, for the control sequence, the expected number of
attempts is larger at the final evaluation compared with the initial one (βλF +βλ(F∗C) > 0);
however, considering only the final evaluation, the expected number of attempts is larger
for the active sequences than for the control ones (βλ(F∗C) < 0).
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Table 6: Estimates of expected values of λ(zλgh)
Disease Evaluation Intervention Sequence Expected Standard
stage session hand value error
Normal Baseline Either Either 5.4 0.2
Normal Final Either Control 7.2 0.3
Normal Final Either Active 9.0 0.4
Initial Baseline Either Either 3.7 0.2
Initial Final Either Control 5.0 0.4
Initial Final Either Active 6.2 0.3
Advanced Baseline Either Either 2.3 0.1
Advanced Final Either Control 3.6 0.2
Advanced Final Either Active 4.4 0.3
Table 7 contains estimates of the expected successful and total attempts along with
the respective standard errors. In Table 8 we present estimates (with respective standard
errors) of the elements of the covariance matrix for normal subjects using the preferred
hand. Covariance patterns for the other subgroups are similar and are not included.
Table 7: Estimates and standard errors (within parentheses) for the expected number of
successful and total attempts under the final beta-binomial/gamma-Poisson model
Disease Evaluation Intervention Sequence Successful Total
stage session hand attempts attempts
Normal Baseline Either Either 17.2 (1.0) 19.8 (1.1)
Normal Final Either Control 21.4 (0.8) 26.4 (0.1)
Normal Final Either Active 31.7 (1.8) 33.0 (1.8)
Initial Baseline Either Either 11.8 (0.7) 13.6 (0.8)
Initial Final Either Control 14.9 (1.1) 18.4 (1.2)
Initial Final Either Active 21.9 (1.4) 22.8 (1.4)
Advanced Baseline Either Either 5.2 (0.6) 8.4 (0.6)
Advanced Final Either Control 6.9 (0.9) 13.2 (0.9)
Advanced Final Either Active 14.0 (1.2) 16.1 (1.1)
4 Discussion
The proposed beta-binomial/gamma-Poisson model is more general than the multivariate
beta-binomial/Poisson model considered in Lora and Singer (2008) because it allows for
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Table 8: Estimates and standard errors (within parentheses) for the expected covariance
matrix for normal subjects using the preferred hand
Baseline session Final session
Active seq. Control seq. Active seq. Control seq.
Suc. Att. Suc. Att. Suc. Att. Suc. Att.
Baseline Active Suc. 51.2
session seq. (7.2)
Att. 42.2 48.5
(11.4) (13.0)
Control Suc. 21.5 0 51.2
seq. (5.8) (7.2)
Att. 0 28.7 42.4 48.5
(7.8) (11.4) (13.0)
Final Active Suc. 40.3 0 40.3 0 118.9
session seq. (10.8) (10.8) (22.2)
Att. 0 48.4 0 48.4 110.5 115.1
(13.0) (13.0) (30.0) (31.2)
Control Suc. 27.3 0 27.3 0 52.3 0 87.4
seq. (7.3) (7.3) (13.8) (12.9)
Att. 0 39.0 0 39.0 0 65.8 64.9 80.1
(10.5) (10.5) (17.7) (17.8) (21.8)
Codes: Suc.=Successes, Att.=Attempts and seq.=sequence
different covariances between the number of attempts in different evaluation sessions and
considers a possible overdispersion of the total attempts. Moreover, the gamma-Poisson
component of the model is computationally much easier to use for comparisons among the
numbers of attempts in different evaluation sessions.
While in the multivariate beta-binomial/Poisson model, the multivariate Poisson com-
ponent requires a different set of parameters for each evaluation session, in the beta-
binomial/gamma-Poisson model, the gamma-Poisson component includes a single set of
parameters for all evaluation sessions. To compare the expected number of attempts under
different conditions using the former, it is necessary rewrite the model and to derive ad
hoc estimating equations while under the latter, it suffices to eliminate the corresponding
regression parameter and to obtain new parameter estimates using the same estimating
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equations. For the analyzed data, for example, the comparison between the control and ac-
tive sequence during the baseline evaluation using the beta-binomial/gamma-Poisson model
is done by testing if the parameter βλC is null. On the other hand, under the multivari-
ate beta-binomial/Poisson approach, the total number of trials is modelled with a specific
vector of parameters for each instant of observation; for the data in the example, they are:
baseline evaluation performing active sequence, baseline evaluation performing the control
sequence, final evaluation performing the active sequence and final evaluation performing
the control sequence. To compare the control and active sequences during the baseline
session we should rewrite the model using only three parameters: baseline evaluation (the
same for active and control sequences), final evaluation performing active sequence and
final evaluation performing control sequence.
The average of the absolute differences between the sample means of the number of
successful and total attempts and the respective expected values under this final model
(Table 7) is 1.7. The same average based on the multivariate beta-binomial/Poisson model
is 0.9. Furthermore, the average of the absolute differences between the observed and
estimated covariances using the multivariate beta-binomial/Poisson model is 21.5 while
it is 19.1 if we use the beta-binomial/gamma-Poisson. These differences are attributable
to the more flexible covariance structure induced by the latter, i.e., allowing for different
covariances between the repeated number of trials.
The values of the AIC ( = 1888.0) and the BIC ( = 1919.1) for the beta-binomial/gamma-
Poisson model compared to the corresponding values (AIC = 1935.6 and BIC = 1974.0)
for the multivariate beta-binomial/Poisson also suggest a better fit of the former.
Although the results are quite similar, with the exception of the values for patients in
the advanced stage of the disease, the beta-binomial/gamma-Poisson one is preferable to
the multivariate beta-binomial/Poisson, both because of the modelling flexibility and the
computational advantages mentioned before.
As an extension for the beta-binomial/gamma-Poisson model, we could incorporate a
parameter to relate the probabilities of success to the total attempts, as in Zhu et al.
(2004). Another possible extension would be to consider the case where attempts could be
done correctly, satisfactorily or incorrectly; in this case, we could generalize the model by
considering Dirichlet-multinomial/gamma-Poisson distribution models. These extensions
are currently under investigation.
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Appendix
First and second derivatives for the gamma-Poisson model
∂L(βλ,βα,βδ)
∂βλ
= Z′λL
[
L−1n− (Ip ⊗B
−1)(1p ⊗ a)
]
,
∂L(βλ,βα,βδ)
∂βα
= Z′αM[c−D
−1log(b)] and
∂L(βλ,βα,βδ)
∂βδ
= Z′δ[De+D
−1Mlog(b)−B−1Lsa]
∂2L(βλ,βα,βδ)
∂βλ∂β
′
λ
= Z′λL[Ip ⊗ (AB
−1)]
{
L[Ip ⊗ (DB
−1)]− IMp
}
Zλ,
∂2L(βλ,βα,βδ)
∂βλ∂β
′
α
= −Z′λL[Ip ⊗ (MB
−1)](1p ⊗ Zα),
∂2L(βλ,βα,βδ)
∂βλ∂β
′
δ
= −Z′λL[Ip ⊗ (DB
−2)] [Ip ⊗ (Ns −MLs)] (1p ⊗ Zδ),
∂2L(βλ,βα,βδ)
∂βα∂β
′
α
= Z′αM
[
C−D−1log(B)−MF
]
Zα,
∂2L(βλ,βα,βδ)
∂βα∂β
′
δ
= Z′αMD
[
−J−D−1B−1Ls +D
−2log(B)
]
Zδ and
∂2L(βλ,βα,βδ)
∂βδ∂β
′
δ
= Z′δD
{
E−DQ+MD−1B−1Ls −D
−2Mlog(B)−B−2Ls [Ns −MLs]
}
Zδ
with L(βλ,βα,βδ) presented in (24) and
a = (a1, ..., ag, ..., aM )
′, ag = δ(zδg)
[
p∑
h=1
ngh
]
+ α(zαg)
A = diag{ag}
B = diag{bg}, bg = δ(zδg)
[
p∑
h=1
λ(zλgh)
]
+ 1
log(b) = (log(b1), ..., log(bg), ..., log(bM ))
′
log(B) = diag{log(bg)}
c = (c1, ..., cg , ..., cM )
′, cg =
Σp
h=1
ngh−1∑
u=0
1
α(zαg) + uδ(zδg)
,
C = diag{cg}
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e = (e1, ..., eg , ..., eM )
′, eg =
Σp
h=1
ngh−1∑
u=0
u
α(zαg) + uδ(zδg)
E = diag{eg},
F = diag{fg}, fg =
Σp
h=1
ngh−1∑
u=0
1
[α(zαg) + uδ(zδg)]2
J = diag{jg}, jg =
Σp
h=1
ngh−1∑
u=0
u
[α(zαg) + uδ(zδg)]2
Q = diag{qg}, qg =
Σp
h=1
ngh−1∑
u=0
[
u
α(zαg) + uδ(zδg)
]2
n = (n11, ..., ngh, ..., nMp)
′,
Ns = diag
{
p∑
h=1
ngh
}
L = diag{λ(zλgh)}
Ls = diag
{
p∑
h=1
λ(zλgh)
}
M = diag{α(zαg)}
D = diag{δ(zδg)}
Zλ = (z
′
λ11, ..., z
′
λgh, ..., z
′
λMp)
′
Zα = (z
′
α1, ..., z
′
αg, ..., z
′
αM )
′
Zδ = (z
′
δ1, ..., z
′
δg, ..., z
′
δM )
′
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